Sign in

CIK 0001817713

  • Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822289112
Phone
+1 858-751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-02 Go William Chief Medical Officer Grant or award · Stock option (right to buy) +154,000 154,000
2026-01-02 Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr Grant or award +36,000 80,000
2026-01-02 Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr Grant or award · Stock option (right to buy) +126,000 126,000
2026-01-02 McIver Zachariah Chief Medical Officer Sale −2,714 $13.73 $37K 23,286
2026-01-02 McIver Zachariah Chief Medical Officer Grant or award +29,000 52,286
2026-01-02 McIver Zachariah Chief Medical Officer Grant or award · Stock option (right to buy) +101,500 101,500
2026-01-02 Dobek Maria Vice President, Accounting Sale −1,462 $13.73 $20K 15,373
2026-01-02 Dobek Maria Vice President, Accounting Grant or award +18,935 34,308
2026-01-02 Dobek Maria Vice President, Accounting Grant or award · Stock option (right to buy) +42,600 42,600
2026-01-02 DiRaimondo Thomas Chief Scientific Officer Sale −2,505 $13.73 $34K 124,425
2026-01-02 DiRaimondo Thomas Chief Scientific Officer Grant or award +31,400 155,825
2026-01-02 DiRaimondo Thomas Chief Scientific Officer Grant or award · Stock option (right to buy) +109,900 109,900
2026-01-02 Winter Charles M. Chief Technical Officer Sale −2,401 $13.73 $33K 77,721
2026-01-02 Winter Charles M. Chief Technical Officer Grant or award +28,600 106,321
2026-01-02 Winter Charles M. Chief Technical Officer Grant or award · Stock option (right to buy) +100,100 100,100
2026-01-02 Meyer Andrew Hollman Chief Business Officer Sale −1,879 $13.73 $26K 83,095
2026-01-02 Campbell David Alan President and CEO Sale −8,072 $13.73 $111K 284,982
2026-01-02 Campbell David Alan President and CEO Grant or award +96,600 381,582
2026-01-02 Campbell David Alan President and CEO Grant or award · Stock option (right to buy) +338,100 338,100
2025-12-01 Meyer Andrew Hollman Chief Business Officer Option exercise 10b5-1 +3,333 $10.59 $35K 88,307

Page 2 of 15 · 294 trades